HER2 overexpression is most commonly associated with breast cancer. Approximately 15-20% of breast cancer cases are HER2-positive. HER2 is also implicated in other types of cancer, such as gastric (stomach) cancer, ovarian cancer, and uterine serous endometrial carcinoma. In these cancers, HER2 positivity also correlates with a more aggressive disease.
